17 12.º FORO DE Inmunología Traslacional e INMUNOTERAPIA DEL CÁNCER 12.50-13.00 CO-01. THERAPEUTIC EFFECT OF GENETICALLY ENGINEERED HER2- AND B7-3- STAB- AND CAR-T CELLS IN A BREAST CANCER MODEL Bravo Martín, C1; Martín García, L1; Sarmiento Tevar, N1; Capelo Mera, E1; Chames, P2; Álvarez Vallina, L3; Sanz Alcober, L4 1Biomedical Research Institute. Hospital Universitario Puerta de Hierro Majadahonda. Majadahonda, Madrid. Spain. 2Aix Marseille Univ, CNRS, INSERM. Institute Paoli-Calmettes, CRCM. Marseille, France. 3Cancer Immunotherapy Unit (UNICA). Department of Immunology. Hospital Universitario 12 de Octubre. Madrid, Spain. 4Molecular Immunology Unit. Biomedical Research Institute Hospital Universitario Puerta de Hierro Majadahonda. Majadahonda, Madrid. Spain 13.00-13.10 CO-02. NEOANTIGEN-LOADED DENDRITIC CELL VACCINE FOR CANCER PREVENTION IN LYNCH SYNDROME: EARLY RESULTS FROM A PHASE IB CLINICAL TRIAL Bayó Llorens, C; Castillo, J; Flórez-Grau, G; Martínez, R; Ramírez, A; Casanovas, B; Rivero, L; Daca, M; Pellisé, M; Ortiz, O; Ocaña, T; Kumari, H; Lozano, M; Charry, P; Castells, A; Juan, M; Benítez-Ribas, D; Balaguer, F IDIBAPS. Hospital Clínic Barcelona. Barcelona 13.10-13.20 GÉTICA 2025 Research Award Lecture CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia Dr. Néstor Tirado. Institut de Recerca contra la Leucèmia Josep Carreras. Barcelona 13.20-14.30 Working lunch 14.35-15.40 Session 5. Neoadjuvant immunotherapy Chairs: Dr. Javier de Castro Carpeño. Hospital Universitario La Paz. Madrid Dra. Elisabeth Pérez Ruiz. Hospital Universitario Virgen de la Victoria. Málaga 14.40-14.55 Setting the scenario: neoadjuvant anti-PD1 immunotherapy a new standard in treatment across cancer types Dra. Inês Pires da Silva. Champalimaud Foundation Melanoma Institute Australia. The University of Sydney. Sidney, Australia 14.55-15.10 Neoadjuvant immunotherapy of head and neck tumours? Dr. Antonio Rueda Domínguez. Hospital Regional Universitario de Málaga. Málaga 15.10-15.25 Neoadjuvant immunotherapy of non-small cell lung cancer? Dr. José Manuel Trigo. HC Marbella International Hospital. Marbella, Málaga 15.25-15.40 Panel discussion and Q&A 15.40-15.55 Award Presentation for the Best Oral Presentation 15.55-16.00 Closing remarks
RkJQdWJsaXNoZXIy MTQzMjMwMg==